1. Home
  2. AMPH vs CRI Comparison

AMPH vs CRI Comparison

Compare AMPH & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • CRI
  • Stock Information
  • Founded
  • AMPH 1996
  • CRI 1865
  • Country
  • AMPH United States
  • CRI United States
  • Employees
  • AMPH N/A
  • CRI N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • CRI Apparel
  • Sector
  • AMPH Health Care
  • CRI Consumer Discretionary
  • Exchange
  • AMPH Nasdaq
  • CRI Nasdaq
  • Market Cap
  • AMPH 1.6B
  • CRI 1.8B
  • IPO Year
  • AMPH 2014
  • CRI 2003
  • Fundamental
  • Price
  • AMPH $31.28
  • CRI $52.07
  • Analyst Decision
  • AMPH Buy
  • CRI Hold
  • Analyst Count
  • AMPH 4
  • CRI 5
  • Target Price
  • AMPH $50.33
  • CRI $65.60
  • AVG Volume (30 Days)
  • AMPH 479.2K
  • CRI 802.9K
  • Earning Date
  • AMPH 03-03-2025
  • CRI 02-25-2025
  • Dividend Yield
  • AMPH N/A
  • CRI 6.15%
  • EPS Growth
  • AMPH 17.38
  • CRI 15.51
  • EPS
  • AMPH 3.01
  • CRI 6.33
  • Revenue
  • AMPH $723,549,000.00
  • CRI $2,842,254,000.00
  • Revenue This Year
  • AMPH $16.22
  • CRI N/A
  • Revenue Next Year
  • AMPH $4.27
  • CRI N/A
  • P/E Ratio
  • AMPH $10.39
  • CRI $8.22
  • Revenue Growth
  • AMPH 20.33
  • CRI N/A
  • 52 Week Low
  • AMPH $30.34
  • CRI $49.65
  • 52 Week High
  • AMPH $56.38
  • CRI $88.03
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 25.63
  • CRI 46.71
  • Support Level
  • AMPH $30.34
  • CRI $50.61
  • Resistance Level
  • AMPH $32.40
  • CRI $53.66
  • Average True Range (ATR)
  • AMPH 0.87
  • CRI 1.73
  • MACD
  • AMPH 0.01
  • CRI 0.07
  • Stochastic Oscillator
  • AMPH 23.21
  • CRI 60.35

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of Carter's sales are in the U.S. and through Carter's brand. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: